Titan Pharmaceuticals Inc (TTNP)

[Serenity3]

wee bit credibility problem from Zacks as they keep ratcheting down thier estimates...anybody recall their former predictions?... didn't see any mention of TTNP sale in the report, which if they don't move on quickly will severely limit their maneuverability... interesting disclosure fine print @ end of report

" The non-investment banking services provided to the issuer includes the preparation of this report, investor relations services, investment software, financial database analysis, organization of non-deal road shows, and attendance fees for conferences sponsored or co-sponsored by Zacks SCR. The fees for these services vary on a per-client basis and are subject to the number and types of services contracted. Fees typically range between ten thousand and fifty thousand dollars per annum. Details of fees paid by this issuer are available upon request."

I particularly chuckled at the report's praise for Braeburn's new CEO.. Mike will fix everything

as far as the touted cash on hand, a big hunk of the $ is the loan they got at payday rates .. the monthly interest payment is heavy & secured by all their assets, except intellectual property.. for now